HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li-Tain Yeh Selected Research

lesinurad

1/2018The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout.
10/2016Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
10/2016Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
6/2016In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor, and Major Liver or Kidney Transporters.
1/2015Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males.
12/2014Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li-Tain Yeh Research Topics

Disease

6Gout
01/2018 - 12/2014
4Body Weight (Weight, Body)
09/2006 - 04/2003
3Neoplasms (Cancer)
01/2016 - 09/2009
3Hepatitis C
06/2005 - 05/2003
3Hemolytic Anemia
08/2004 - 05/2003
2Hyperuricemia
01/2018 - 10/2016
2Melanoma (Melanoma, Malignant)
03/2013 - 09/2009
2Infections
02/2007 - 03/2005
2Chronic Hepatitis C
03/2004 - 05/2003
1Carcinoma (Carcinomatosis)
09/2009
1HIV Infections (HIV Infection)
02/2007
1Chronic Hepatitis B
11/2004
1Hyperplasia
08/2004
1Hepatitis B
04/2004

Drug/Important Bio-Agent (IBA)

8Ribavirin (Virazole)FDA LinkGeneric
06/2005 - 04/2003
6lesinuradIBA
01/2018 - 12/2014
6Uric Acid (Urate)IBA
01/2018 - 12/2014
4taribavirin (viramidine)IBA
03/2005 - 05/2003
3ProdrugsIBA
03/2005 - 08/2003
2Xanthine OxidaseIBA
01/2018 - 12/2014
2N- (3,4- difluoro- 2- (2- fluoro- 4- iodophenylamino)- 6- methoxyphenyl)- 1- (2,3- dihydroxypropyl)cyclopropane- 1- sulfonamideIBA
01/2016 - 09/2009
2pradefovirIBA
09/2006 - 03/2005
1Allopurinol (Remid)FDA LinkGeneric
01/2018
1urate transporterIBA
10/2016
1Pharmaceutical PreparationsIBA
10/2016
1Probenecid (Benemid)FDA LinkGeneric
10/2016
1BenzbromaroneIBA
10/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2016
1Sorafenib (BAY 43-9006)FDA Link
01/2016
1ColchicineFDA LinkGeneric
12/2014
1FebuxostatFDA Link
12/2014
1Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
03/2013
1VRX-480773IBA
02/2007
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2007
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
09/2006
1adefovir dipivoxil (Hepsera)FDA Link
11/2004
1EsterasesIBA
11/2004
1Hemoglobins (Hemoglobin)IBA
08/2004
1adefovirIBA
04/2004
1Antiviral Agents (Antivirals)IBA
04/2004

Therapy/Procedure

9Therapeutics
01/2018 - 05/2003
3Oral Administration
03/2005 - 04/2003